At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 40 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Placebo Controlled Study Among Children Below Four Years of Age, Investigating Whether a Glucose Oxidase Nasal Spray Can Reduce Days With Upper Respiratory Tract Infection Symptoms
In Brief
A Phase 2 clinical trial evaluating Placebo and Glucose oxidase for Upper Respiratory Tract Infections. Completed, enrolled 40 participants across 4 sites.
Detailed Summary
To investigate if use of glucosoxidas nasal spray can reduce the number of days with upper respiratory tract infections in children beyond 4 years.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUpper Respiratory Tract Infections
CountriesSweden
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
Primary CompletionMay 2013
Study CompletionJun 2013
First PostedJun 2013
TodayJul 2026
First PostedJun 21, 2013
Enrollment StartOct 1, 2012
Primary CompletionMay 1, 2013
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.0 years ago
Interventions
Placebodrug
placebo containing saline+glucose
Glucose oxidasedrug
a hydrogen peroxide producing enzyme that creates an acidous environment to which rhinoviruses are sensitive.